SUN Pharmaceutical Industries Limited Ketorolac Export Data — India (DGFT 2022–2026)

Name: SUN Pharmaceutical Industries Limited Ketorolac Export Records India — #2 Exporter, 95 Shipments, $4.8M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus
Published: 2026-05-01T00:00:00Z
License: https://transdatanexus.com/terms-and-conditions

Suresh Sormare

Ketorolac

India Pharmaceutical Trade Intelligence

$115.9M351 Suppliers124 CountriesHS 30049067

ExportsIndia → UNITED STATES63.1%India → RUSSIA23.4%

ImportsUNITED STATES → India$722.1K UNITED KINGDOM → India$13.4K

#1 Supplier: GLAND PHARMA #1 Buyer: EVERSANA LIFE

SUN Pharmaceutical Industries Limited — Ketorolac Exporter #2 | $4.8M Trade Value | TransData Nexus | TransData Nexus

SUN Pharmaceutical Industries Limited — Ketorolac Exporter Profile

Indian Pharmaceutical Exporter · #2 for Ketorolac · $4.8M export value · DGFT Verified

SUN Pharmaceutical Industries Limited is the #2 Indian exporter of Ketorolac with $4.8M in export value and 95 verified shipments. SUN Pharmaceutical Industries Limited holds a 4.1% market share in Ketorolac exports across 3 countries. The company exports 118 pharmaceutical products worth $979.8M across 25 therapeutic categories.

SUN Pharmaceutical Industries Limited — Ketorolac Export Profile: Buyers & Destinations

SUN Pharmaceutical Industries Limited Ketorolac export treemap — buyers and destination countries | TransData Nexus

Where Does SUN Pharmaceutical Industries Limited Export Ketorolac?

Country	Value	Shipments	Share
RUSSIA	$4.2M	87	92.7%
IRAN	$218.7K	6	4.8%
UNITED STATES	$112.0K	7	2.5%
NIGERIA	$149	1	0.0%

Who Are the Top Buyers of Ketorolac from SUN Pharmaceutical Industries Limited?

Buyer	Country	Value	Orders
AO RANBAXY	RUSSIA	$2.7M	56
AO "RANBAXY"	RUSSIA	$1.6M	34
SUN PHARMACEUTICAL INDUSTRIES,INC.	UNITED STATES	$112.0K	7
AO RANBAXY -	RUSSIA	$59.9K	2
MULTI SMARTLINE RESOURCES LTD.	NIGERIA	$149	1
REPRESENTATIVE OFFICE OF SUN	RUSSIA	$24	1

SUN Pharmaceutical Industries Limited supplies Ketorolac to 6 buyers globally. The largest buyer is AO RANBAXY (RUSSIA), followed by AO "RANBAXY" (RUSSIA) and SUN PHARMACEUTICAL INDUSTRIES,INC. (UNITED STATES). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.

What Ketorolac Formulations Does SUN Pharmaceutical Industries Limited Export?

Product Description / Formulation	Value	Shipments
KETOROLAC TROMETAMOL MD TABS 10 MG (KETANOV TABS) (PACK :BOX20S)	$218.7K	6
KETANOV TABLETS 10MG PACK : BOX20S BATCH: DFE8576A, DFE8633A, DFF0021A EACH TABCONTS KETOROLAC TROMETHAMINE 10 MGPCS	$150.0K	3
KETANOV TABLETS 10MG PACK:BOX20S BATCH:DFF0457A, DFF0458A, DFF0521A EACH TAB CONTS. KETOROLAC TROMETHAMINE 10MGPCS	$150.0K	3
KETANOV TABLETS 10MG PACK:BOX20S BATCH:DFF1838A, DFF1839A, DFF1898A EACH TAB CONTS. KETOROLAC TROMETHAMINE 10 MG	$150.0K	3
KETANOV TABLETS 10MG PACK:BOX20S BATCH:DFF1897A, DFF2060A, DFF2061A, DFF2061B EACH TAB CONTS. KETOROLAC TROMETHAMINE 10	$150.0K	3
Ketanov MD Tablet 10mg EACH TABELT CONTAINS KETOROLAC TROMETAMOL PH.EUR 10 MG (PACK :Box20s) (KETOROLAC TROMETAMOL MOUTH	$150.0K	3
KETOROLAC TROMETHAMINE OPHTHALMIC SOLUTI	$112.0K	7
KETANOV TABLETS 10MG PACK:BOX10X10s BATCH:DFF7950A, DFF7951A EACH TAB CONTS.KETOROLAC TROMETHAMINE 10MG	$100.0K	2
KETANOV TABLETS 10MG PACK:BOX20s BATCH:DFF3061A EACH TAB CONTS. KETOROLAC TROMETHAMINE 10MG	$88.3K	3
KETANOV TABLETS 10MG PACK Box20s Batch DFE0572B DFE0573A DFE0574A EACH TAB CONTS KETOROLAC TROMETHAMINE 10 MG	$50.0K	1

SUN Pharmaceutical Industries Limited exports 77 distinct Ketorolac formulations including tablets, capsules, syrups, and combination drugs. The top formulation is KETOROLAC TROMETAMOL MD TABS 10 MG (KETANOV TABS) (PACK :BOX with 6 shipments worth $218.7K.

How Does SUN Pharmaceutical Industries Limited Compare to Nearest Ketorolac Exporters?

Exporters ranked immediately above and below #2 by export value

#	Supplier	Export Value	Shipments	Countries	Avg/Shipment
1	GLAND PHARMA LIMITED	$10.6M	212	5	$50.0K
3	GLAND PHARMA LTD	$9.7M	193	5	$50.0K
2	SUN PHARMACEUTICAL INDUSTRIES LIMITED ★	$4.8M	95	3	$50.0K
4	ALEMBIC PHARMACEUTICALS LIMITED	$3.5M	70	1	$50.0K
6	MICRO LABS LIMITED	$3.0M	60	10	$50.0K

SUN Pharmaceutical Industries Limited ranks #2 among 351 Indian Ketorolac exporters. Average shipment value of $50.0K compared to the market average of $141.1K. The closest competitors by value are GLAND PHARMA LIMITED and GLAND PHARMA LTD.

Which Indian Ports Ship Ketorolac Exports?

Port	Shipments	% Share
SAHAR AIR CARGO ACC (INBOM4)	337	11.4%
SAHAR AIR	229	7.7%
NHAVA SHEVA SEA (INNSA1)	227	7.7%
HYDERABAD ICD (INSNF6)	127	4.3%
HYDERABAD AIR	93	3.1%
DELHI AIR	92	3.1%
DELHI AIR CARGO ACC (INDEL4)	75	2.5%
HYDERABAD ICD	74	2.5%

Geopolitical & Trade Policy Impact on SUN Pharmaceutical Industries Limited's Ketorolac Exports

Sun Pharma's export operations, valued at $979.8 million, are significantly influenced by current geopolitical events. The ongoing Israel-Iran tensions have led to disruptions in the Red Sea shipping routes, a critical corridor for Indian pharmaceutical exports to Europe and North Africa. Major shipping lines have imposed 'Emergency Risk Surcharges,' increasing freight costs and extending transit times by 10–15 days. These delays pose risks to the integrity of time-sensitive and temperature-controlled pharmaceutical shipments. (pharmaceuticalcommerce.com)

In the United States, policy shifts towards domestic manufacturing and the imposition of tariffs on imported pharmaceuticals have created challenges for Indian exporters. Sun Pharma, which supplies a substantial portion of generics to the U.S. market, faces potential reductions in export volumes due to these protectionist measures. The company is exploring strategies such as establishing local partnerships and investing in U.S.-based manufacturing to mitigate these impacts. (odrindia.in)

The European Union's implementation of the Carbon Border Adjustment Mechanism (CBAM) introduces additional compliance requirements for exporters. Sun Pharma must adapt to these regulations to maintain its market presence in the EU, necessitating investments in sustainable manufacturing practices and comprehensive reporting mechanisms. (sgeexport.com)

SUN Pharmaceutical Industries Limited — Regulatory Compliance & Quality Standards

Compliance with international regulatory standards remains a critical focus for Sun Pharma. The company has encountered challenges with the U.S. FDA, including import alerts and non-compliance letters for certain facilities. Addressing these issues involves implementing corrective actions and awaiting reinspection to resume full operations. (business-standard.com)

Globally, the pharmaceutical industry faces increasing scrutiny regarding quality standards. Sun Pharma's commitment to adhering to Good Manufacturing Practices (GMP) and other regulatory requirements is essential to maintain its export licenses and market reputation. Continuous investment in quality control systems and compliance infrastructure is imperative to navigate the evolving regulatory landscape.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Product Matching: Ketorolac shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
2.Supplier Identification: SUN Pharmaceutical Industries Limited matched across shipments using name normalization, accounting for company name formatting variations.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
4.Verified Records: This page is backed by 101 individual customs records matching SUN Pharmaceutical Industries Limited exporting Ketorolac, covering 77 formulations to 4 countries via 6 buyers.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

Global Coverage

Exports to 124+ countries, 638+ buyers

Expert-Reviewed

Analyzed by pharmaceutical trade specialists

Ketorolac

Ketorolac

SUN Pharmaceutical Industries Limited — Ketorolac Exporter Profile

SUN Pharmaceutical Industries Limited — Ketorolac Export Profile: Buyers & Destinations

Where Does SUN Pharmaceutical Industries Limited Export Ketorolac?

Who Are the Top Buyers of Ketorolac from SUN Pharmaceutical Industries Limited?

What Is India's Total Ketorolac Export Value and How Much Does SUN Pharmaceutical Industries Limited Contribute?

What Is the Average Shipment Value for SUN Pharmaceutical Industries Limited's Ketorolac Exports?

How Does SUN Pharmaceutical Industries Limited Compare to Other Indian Ketorolac Exporters?

What Ketorolac Formulations Does SUN Pharmaceutical Industries Limited Export?

Regulatory Requirements: Exporting Ketorolac to Key Markets

United States — FDA

How Does SUN Pharmaceutical Industries Limited Compare to Nearest Ketorolac Exporters?

Which Indian Ports Ship Ketorolac Exports?

Ketorolac — Export Intelligence Video

Geopolitical & Trade Policy Impact on SUN Pharmaceutical Industries Limited's Ketorolac Exports

SUN Pharmaceutical Industries Limited — Regulatory Compliance & Quality Standards

About SUN Pharmaceutical Industries Limited

Market Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Get Ketorolac Export Data from SUN Pharmaceutical Industries Limited

Ketorolac Stats

Company Overview

Top Products by SUN Pharmaceutical Industries Limited

Related Analysis

Need Detailed Export Data?

Data Source